<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Genitourinary Syndrome of Menopause (GSM)</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - Orchid/Plum theme for Intimate Health */
        .module-header {
            background: linear-gradient(135deg, #7c3aed 0%, #a855f7 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #a855f7;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #7c3aed;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #f3e8ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #6d28d9;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            color: #4b5563;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #374151;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: #fcfaff;
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            border: 1px solid #e9d5ff;
            box-shadow: 0 4px 15px rgba(124, 58, 237, 0.05);
        }

        .case-study-header {
            background: #7c3aed;
            padding: 20px 30px;
            color: white;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            background: white;
            padding: 20px;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #f3e8ff;
            display: flex;
            gap: 20px;
            align-items: center;
        }

        .patient-avatar {
            width: 60px;
            height: 60px;
            background: #ddd6fe;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Alert/Info Boxes */
        .alert-box {
            padding: 25px;
            border-radius: 12px;
            margin: 30px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fffbeb;
            border-left-color: #f59e0b;
            color: #92400e;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
            color: #1e40af;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #d4a84b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            padding: 20px;
            border-radius: 10px;
            margin-bottom: 15px;
            border: 1px solid #e5e7eb;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 6px;
            color: #5b21b6;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-list {
            list-style: none;
            padding: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 120px;
            margin-bottom: 10px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Advanced Physiological Systems & Longevity</p>
            <h1 class="lesson-title">Lesson 9.4: Genitourinary Syndrome of Menopause (GSM)</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pathophysiology"><span class="section-num">1</span>Pathophysiology & pH Shifts</a></li>
                <li><a href="#diagnosis"><span class="section-num">2</span>Differentiating GSM vs. Infection</a></li>
                <li><a href="#non-hormonal"><span class="section-num">3</span>Non-Hormonal Interventions</a></li>
                <li><a href="#hormonal"><span class="section-num">4</span>Local vs. Systemic HRT</a></li>
                <li><a href="#pelvic-floor"><span class="section-num">5</span>PFPT & Structural Support</a></li>
                <li><a href="#coaching"><span class="section-num">6</span>The THRIVE Coaching Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the biological mechanism behind vaginal pH elevation and Lactobacillus depletion.</li>
                <li>Identify the "Red Flag" symptoms requiring medical referral versus coaching support.</li>
                <li>Compare the efficacy and safety profiles of local estradiol vs. systemic hormone therapy.</li>
                <li>Evaluate non-hormonal options including hyaluronic acid and Vitamin E suppositories.</li>
                <li>Understand the role of Pelvic Floor Physical Therapy in managing hypertonic muscle states.</li>
            </ul>
        </div>

        <h2 id="pathophysiology">1. The Pathophysiology of GSM: Beyond "Dryness"</h2>
        <p>For decades, the medical community used the term "Vulvovaginal Atrophy" (VVA). However, in 2014, the North American Menopause Society (NAMS) and the International Society for the Study of Women's Sexual Health (ISSWSH) adopted the more comprehensive term: <span class="highlight">Genitourinary Syndrome of Menopause (GSM)</span>.</p>
        
        <p>GSM describes a collection of signs and symptoms resulting from a decrease in estrogen and other sex steroids involving changes to the labia, clitoris, vagina, urethra, and bladder. Unlike vasomotor symptoms (hot flashes), which often resolve over time, GSM is typically <span class="highlight">progressive and unlikely to resolve without intervention</span>.</p>

        <h3>The Estrogen-Microbiome Axis</h3>
        <p>In the pre-menopausal state, high levels of estrogen promote the proliferation of vaginal epithelial cells. These cells produce <strong>glycogen</strong>, which is the primary food source for <strong>Lactobacillus</strong> species (specifically <i>L. crispatus</i> and <i>L. jensenii</i>). As these bacteria metabolize glycogen, they produce <strong>lactic acid</strong>, maintaining a healthy, acidic vaginal pH of 3.8 to 4.5.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">5.0+</div>
                    <div class="stat-label">Post-Meno pH</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">84%</div>
                    <div class="stat-label">Women Untreated</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Prevalence</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3x</div>
                    <div class="stat-label">UTI Risk Increase</div>
                </div>
            </div>
        </div>

        <p>As estrogen declines, the vaginal epithelium thins (atrophy), glycogen production ceases, and the Lactobacillus population collapses. This leads to a rise in vaginal pH (often >5.0), which allows for the overgrowth of opportunistic pathogens and a significant increase in the risk of <span class="highlight">Urinary Tract Infections (UTIs)</span> and Bacterial Vaginosis (BV).</p>

        <h2 id="diagnosis">2. Differentiating GSM from Common Infections</h2>
        <p>One of the greatest challenges for the Menopause Support Coach is helping clients distinguish between the chronic symptoms of GSM and acute infections. Many women spend years treating "recurrent yeast infections" with over-the-counter antifungals, when the underlying issue is actually tissue friability and pH imbalance due to GSM.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>GSM (Atrophy)</th>
                        <th>Yeast Infection (Candidiasis)</th>
                        <th>Bacterial Vaginosis (BV)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Symptom</strong></td>
                        <td>Dryness, Burning, Dyspareunia</td>
                        <td>Intense Itching, Soreness</td>
                        <td>Thin Discharge, "Fishy" Odor</td>
                    </tr>
                    <tr>
                        <td><strong>Discharge</strong></td>
                        <td>Minimal/Absent</td>
                        <td>Thick, "Cottage Cheese"</td>
                        <td>Grey/White, Milky</td>
                    </tr>
                    <tr>
                        <td><strong>Vaginal pH</strong></td>
                        <td>&gt; 5.0 (Alkaline)</td>
                        <td>&lt; 4.5 (Normal Acidic)</td>
                        <td>&gt; 4.5 (Alkaline)</td>
                    </tr>
                    <tr>
                        <td><strong>Urinary Signs</strong></td>
                        <td>Urgency, Frequency, Nocturia</td>
                        <td>External Burning only</td>
                        <td>Rarely affects bladder</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="alert-box warning">
            <p class="alert-label">‚ö†Ô∏è RED FLAG PROTOCOL: POSTMENOPAUSAL BLEEDING</p>
            <p>While GSM can cause light spotting after intercourse due to tissue friability (tearing), <strong>any</strong> postmenopausal bleeding must be referred to a gynecologist immediately to rule out endometrial hyperplasia or malignancy. As a coach, you never assume bleeding is "just atrophy."</p>
        </div>

        <h2 id="non-hormonal">3. Non-Hormonal Interventions: The Science of Moisture</h2>
        <p>For clients who cannot or choose not to use hormone therapy, non-hormonal interventions are the first line of defense. However, it is vital to distinguish between <strong>lubricants</strong> and <strong>moisturizers</strong>.</p>

        <h3>Vaginal Moisturizers vs. Lubricants</h3>
        <ul>
            <li><strong>Lubricants:</strong> Used specifically for sexual activity to reduce friction. Water-based, silicone-based, or oil-based. *Note: Oil-based lubricants can degrade latex condoms.*</li>
            <li><strong>Moisturizers:</strong> Used 2‚Äì3 times weekly (regardless of sexual activity) to trap moisture in the tissues and lower pH.</li>
        </ul>

        <p><strong>The Hyaluronic Acid (HA) Advantage:</strong> A 2021 meta-analysis published in <i>The Journal of Sexual Medicine</i> found that vaginal hyaluronic acid (5mg) was non-inferior to vaginal estriol (0.5mg) in improving GSM symptoms. HA works by binding to water molecules, creating a hydrated environment that supports tissue elasticity and wound healing.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The "Chronic UTI" Trap</p>
                    <p class="subtitle">Client: Elena, Age 54</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 54, Post-Menopausal</h4>
                        <p>Presenting: 3 UTIs in the last 6 months, painful intercourse, and constant "bladder pressure."</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Working with her GP, we confirmed her UTIs were triggered by intercourse. We implemented the <strong>THRIVE 'T' (Track)</strong> protocol to map symptoms. Elena began using a high-molecular-weight Hyaluronic Acid suppository 3x weekly and a pH-balanced silicone lubricant during intimacy.</p>
                <p><strong>Outcomes:</strong> After 8 weeks, vaginal pH dropped from 5.8 to 4.7. Elena reported a 70% reduction in urinary urgency and has remained UTI-free for 5 months. She also integrated Pelvic Floor Physical Therapy to address "guarding" (muscle tension) caused by previous pain.</p>
            </div>
        </div>

        <h2 id="hormonal">4. Local vs. Systemic HRT: Understanding the Safety Profile</h2>
        <p>One of the most common misconceptions clients have is that vaginal estrogen carries the same risks as systemic HRT (pills/patches). It is critical to educate clients on the <span class="highlight">minimal systemic absorption</span> of local therapies.</p>

        <p>Local vaginal estrogen (estradiol or estriol) is delivered in extremely low doses. For example, a year's worth of local vaginal estrogen therapy contains approximately the same amount of estrogen as <span class="highlight">one single systemic HRT pill</span>. Because of this, NAMS guidelines state that for women with GSM only, local therapy is preferred, and a progestogen is <strong>not</strong> required for endometrial protection.</p>

        <h3>Delivery Methods</h3>
        <ul>
            <li><strong>Vaginal Creams:</strong> Allows for application to the vulva and vestibule (excellent for external irritation).</li>
            <li><strong>Vaginal Tablets/Inserts:</strong> Mess-free, pre-measured doses (e.g., Vagifem).</li>
            <li><strong>Vaginal Rings:</strong> A soft, flexible ring (e.g., Estring) that stays in place for 90 days, providing continuous low-dose release.</li>
            <li><strong>DHEA (Prasterone):</strong> A daily vaginal insert that is converted into both estrogen and testosterone within the vaginal cells.</li>
        </ul>

        <h2 id="pelvic-floor">5. The Role of Pelvic Floor Physical Therapy (PFPT)</h2>
        <p>While hormones and moisturizers address the <i>tissue</i>, they do not always address the <i>muscles</i>. Chronic pain from GSM often leads to a condition called <strong>hypertonicity</strong>‚Äîwhere the pelvic floor muscles become "locked" in a contracted state as a protective mechanism against pain.</p>

        <p><strong>Pelvic Organ Prolapse (POP):</strong> The decline in collagen and estrogen also affects the connective tissue supporting the bladder, uterus, and rectum. PFPT is essential for:
        <ul>
            <li>Down-training overactive muscles to alleviate dyspareunia.</li>
            <li>Strengthening the "pelvic hammock" to manage stage 1 or 2 prolapse.</li>
            <li>Improving the "knack"‚Äîa timed contraction to prevent stress urinary incontinence (SUI) during coughing or sneezing.</li>
        </ul></p>

        <div class="alert-box info">
            <p class="alert-label">üí° PRACTITIONER TIP</p>
            <p>A Menopause Coach should have at least 2-3 trusted Pelvic Floor Physical Therapists in their referral network. If a client reports "burning" that doesn't resolve with moisture, or a feeling of "heaviness" in the pelvis, a PFPT evaluation is the gold standard.</p>
        </div>

        <h2 id="coaching">6. Integrating GSM Support into the THRIVE‚Ñ¢ Framework</h2>
        <p>As we conclude Module 9, we see how GSM fits into the holistic transformation of your clients. Intimate health is not a "luxury"‚Äîit is a pillar of vitality and long-term wellness.</p>

        <div class="principle-card">
            <p class="principle-title">T: Track Symptoms</p>
            <p class="principle-text">Use a 1-10 scale for dryness and urgency. Track the relationship between intimacy and subsequent urinary symptoms.</p>
        </div>
        <div class="principle-card">
            <p class="principle-title">H: Hormone Harmony</p>
            <p class="principle-text">Educate on the difference between local and systemic options so the client can have an informed conversation with their doctor.</p>
        </div>
        <div class="principle-card">
            <p class="principle-title">V: Vitality Boost</p>
            <p class="principle-text">Address how nocturia (waking up to pee) is destroying their sleep architecture (covered in Module 5) and causing daytime fatigue.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of GSM management.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why does vaginal pH rise during menopause, and what is the primary consequence?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">Vaginal pH rises because the loss of estrogen leads to a decrease in glycogen. Without glycogen, Lactobacillus (acid-producing bacteria) cannot thrive. The consequence is an alkaline environment (pH >5.0) that is susceptible to UTIs and pathogens.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. True or False: A woman using local vaginal estrogen cream usually needs to take oral progesterone to protect her uterus.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">False. Local vaginal estrogen has minimal systemic absorption, and current NAMS guidelines state that progestogen is generally not required for endometrial protection with low-dose local therapy.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>GSM is a chronic, progressive condition affecting roughly 50% of postmenopausal women, yet only 7-10% receive treatment.</li>
                <li>The "Gold Standard" for non-hormonal treatment is high-molecular-weight Hyaluronic Acid (5mg) used 2-3 times weekly.</li>
                <li>Local estrogen therapy is highly safe and effective, with negligible systemic absorption compared to oral or transdermal HRT.</li>
                <li>Pelvic Floor Physical Therapy is a critical adjunct to address muscle hypertonicity and prolapse that hormones alone cannot fix.</li>
                <li>Always refer "Red Flag" postmenopausal bleeding to a medical professional immediately.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>NAMS (2020). "The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society." Menopause Journal.</li>
                <li>Portman, D. J., et al. (2014). "Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy." Menopause.</li>
                <li>Gandhi, J., et al. (2016). "Genitourinary syndrome of menopause: an overview of clinical manifestations, psycho-social implications, and management." American Journal of Obstetrics & Gynecology.</li>
                <li>Cucinella, G., et al. (2021). "Hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women: a systematic review." Journal of Sexual Medicine.</li>
                <li>Faubion, S. S., et al. (2017). "Genitourinary Syndrome of Menopause: Management Strategies for the Clinician." Mayo Clinic Proceedings.</li>
                <li>Palacios, S., et al. (2019). "A multi-center, randomized, double-blind study of a non-hormonal vaginal moisturizer." Maturitas.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy‚Ñ¢ | Menopause Support Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary THRIVE‚Ñ¢ Methodology.</p>
        </footer>
    </div>
</body>

</html>